nodes	percent_of_prediction	percent_of_DWPC	metapath
Halothane—ND1—oviduct—ovarian cancer	0.0234	0.0489	CbGeAlD
Halothane—RHO—epithelium—ovarian cancer	0.0191	0.0399	CbGeAlD
Halothane—KCNJ6—female reproductive system—ovarian cancer	0.0133	0.0277	CbGeAlD
Halothane—GNG2—decidua—ovarian cancer	0.0116	0.0243	CbGeAlD
Halothane—GRIN3B—testis—ovarian cancer	0.0111	0.0231	CbGeAlD
Halothane—GNG2—gonad—ovarian cancer	0.0102	0.0214	CbGeAlD
Halothane—GNG2—female reproductive system—ovarian cancer	0.00915	0.0191	CbGeAlD
Halothane—GNG2—bone marrow—ovarian cancer	0.00864	0.018	CbGeAlD
Halothane—GNG2—female gonad—ovarian cancer	0.00833	0.0174	CbGeAlD
Halothane—GNG2—vagina—ovarian cancer	0.00828	0.0173	CbGeAlD
Halothane—KCNN4—myometrium—ovarian cancer	0.00796	0.0166	CbGeAlD
Halothane—GNG2—testis—ovarian cancer	0.00739	0.0154	CbGeAlD
Halothane—GLRB—uterine cervix—ovarian cancer	0.00729	0.0152	CbGeAlD
Halothane—KCNK3—female reproductive system—ovarian cancer	0.0063	0.0132	CbGeAlD
Halothane—KCNN4—epithelium—ovarian cancer	0.00625	0.0131	CbGeAlD
Halothane—KCNMA1—myometrium—ovarian cancer	0.00609	0.0127	CbGeAlD
Halothane—ATP5D—myometrium—ovarian cancer	0.00604	0.0126	CbGeAlD
Halothane—ATP2C1—myometrium—ovarian cancer	0.00596	0.0124	CbGeAlD
Halothane—KCNN4—decidua—ovarian cancer	0.0059	0.0123	CbGeAlD
Halothane—KCNK2—vagina—ovarian cancer	0.0059	0.0123	CbGeAlD
Halothane—KCNN4—endometrium—ovarian cancer	0.00561	0.0117	CbGeAlD
Halothane—GNG2—lymph node—ovarian cancer	0.00535	0.0112	CbGeAlD
Halothane—KCNK2—testis—ovarian cancer	0.00526	0.011	CbGeAlD
Halothane—KCNN4—uterus—ovarian cancer	0.00517	0.0108	CbGeAlD
Halothane—GLRB—vagina—ovarian cancer	0.00494	0.0103	CbGeAlD
Halothane—ND1—gonad—ovarian cancer	0.00489	0.0102	CbGeAlD
Halothane—KCNMA1—epithelium—ovarian cancer	0.00478	0.00998	CbGeAlD
Halothane—ATP5D—uterine cervix—ovarian cancer	0.0047	0.00981	CbGeAlD
Halothane—GRIN3A—testis—ovarian cancer	0.00465	0.00971	CbGeAlD
Halothane—KCNN4—female reproductive system—ovarian cancer	0.00464	0.0097	CbGeAlD
Halothane—ATP2C1—uterine cervix—ovarian cancer	0.00464	0.00968	CbGeAlD
Halothane—GABRP—uterine cervix—ovarian cancer	0.00454	0.00949	CbGeAlD
Halothane—KCNMA1—decidua—ovarian cancer	0.00452	0.00943	CbGeAlD
Halothane—ATP5D—decidua—ovarian cancer	0.00447	0.00935	CbGeAlD
Halothane—GABRE—myometrium—ovarian cancer	0.00446	0.00931	CbGeAlD
Halothane—ATP2C1—decidua—ovarian cancer	0.00442	0.00922	CbGeAlD
Halothane—KCNN4—bone marrow—ovarian cancer	0.00438	0.00916	CbGeAlD
Halothane—ND1—female reproductive system—ovarian cancer	0.00437	0.00912	CbGeAlD
Halothane—GABRP—decidua—ovarian cancer	0.00433	0.00904	CbGeAlD
Halothane—ATP5D—endometrium—ovarian cancer	0.00425	0.00887	CbGeAlD
Halothane—KCNN4—vagina—ovarian cancer	0.0042	0.00877	CbGeAlD
Halothane—ATP2C1—endometrium—ovarian cancer	0.00419	0.00876	CbGeAlD
Halothane—ND1—bone marrow—ovarian cancer	0.00412	0.00861	CbGeAlD
Halothane—GRIN2A—vagina—ovarian cancer	0.00412	0.0086	CbGeAlD
Halothane—GABRP—endometrium—ovarian cancer	0.00411	0.00858	CbGeAlD
Halothane—KCNMA1—gonad—ovarian cancer	0.00398	0.0083	CbGeAlD
Halothane—ND1—female gonad—ovarian cancer	0.00397	0.0083	CbGeAlD
Halothane—GABRG3—testis—ovarian cancer	0.00397	0.00829	CbGeAlD
Halothane—KCNMA1—uterus—ovarian cancer	0.00395	0.00825	CbGeAlD
Halothane—ATP5D—gonad—ovarian cancer	0.00394	0.00823	CbGeAlD
Halothane—ATP5D—uterus—ovarian cancer	0.00391	0.00818	CbGeAlD
Halothane—ATP2C1—gonad—ovarian cancer	0.00389	0.00812	CbGeAlD
Halothane—ATP2C1—uterus—ovarian cancer	0.00386	0.00807	CbGeAlD
Halothane—KCNK2—lymph node—ovarian cancer	0.00381	0.00797	CbGeAlD
Halothane—GABRP—uterus—ovarian cancer	0.00379	0.00791	CbGeAlD
Halothane—KCNN4—testis—ovarian cancer	0.00375	0.00783	CbGeAlD
Halothane—GRIN2A—testis—ovarian cancer	0.00367	0.00768	CbGeAlD
Halothane—KCNMA1—female reproductive system—ovarian cancer	0.00355	0.00742	CbGeAlD
Halothane—ND1—testis—ovarian cancer	0.00352	0.00736	CbGeAlD
Halothane—ATP5D—female reproductive system—ovarian cancer	0.00352	0.00735	CbGeAlD
Halothane—ATP2C1—female reproductive system—ovarian cancer	0.00347	0.00725	CbGeAlD
Halothane—GABRE—uterine cervix—ovarian cancer	0.00347	0.00724	CbGeAlD
Halothane—GABRB1—vagina—ovarian cancer	0.00344	0.00718	CbGeAlD
Halothane—GABRP—female reproductive system—ovarian cancer	0.0034	0.00711	CbGeAlD
Halothane—ATP5D—bone marrow—ovarian cancer	0.00332	0.00694	CbGeAlD
Halothane—GABRE—decidua—ovarian cancer	0.0033	0.0069	CbGeAlD
Halothane—GABRD—testis—ovarian cancer	0.00329	0.00686	CbGeAlD
Halothane—ATP2C1—bone marrow—ovarian cancer	0.00328	0.00685	CbGeAlD
Halothane—ATP5D—female gonad—ovarian cancer	0.0032	0.00669	CbGeAlD
Halothane—GLRB—lymph node—ovarian cancer	0.00319	0.00667	CbGeAlD
Halothane—ATP5D—vagina—ovarian cancer	0.00318	0.00665	CbGeAlD
Halothane—ATP2C1—female gonad—ovarian cancer	0.00316	0.0066	CbGeAlD
Halothane—ATP2C1—vagina—ovarian cancer	0.00314	0.00656	CbGeAlD
Halothane—GABRE—endometrium—ovarian cancer	0.00314	0.00655	CbGeAlD
Halothane—GABRP—vagina—ovarian cancer	0.00308	0.00643	CbGeAlD
Halothane—GABRA5—testis—ovarian cancer	0.00305	0.00637	CbGeAlD
Halothane—KCNMA1—testis—ovarian cancer	0.00287	0.00598	CbGeAlD
Halothane—GABRA3—testis—ovarian cancer	0.00284	0.00593	CbGeAlD
Halothane—ATP5D—testis—ovarian cancer	0.00284	0.00593	CbGeAlD
Halothane—ATP2C1—testis—ovarian cancer	0.0028	0.00585	CbGeAlD
Halothane—KCNN4—lymph node—ovarian cancer	0.00272	0.00567	CbGeAlD
Halothane—CYP2A6—vagina—ovarian cancer	0.00268	0.0056	CbGeAlD
Halothane—GABRE—female reproductive system—ovarian cancer	0.0026	0.00543	CbGeAlD
Halothane—ND1—lymph node—ovarian cancer	0.00255	0.00533	CbGeAlD
Halothane—GABRB3—gonad—ovarian cancer	0.00247	0.00515	CbGeAlD
Halothane—GABRA2—vagina—ovarian cancer	0.00237	0.00495	CbGeAlD
Halothane—GABRE—female gonad—ovarian cancer	0.00236	0.00494	CbGeAlD
Halothane—GABRE—vagina—ovarian cancer	0.00235	0.00491	CbGeAlD
Halothane—GABRB2—testis—ovarian cancer	0.00232	0.00484	CbGeAlD
Halothane—GABRB3—female reproductive system—ovarian cancer	0.0022	0.0046	CbGeAlD
Halothane—GABRE—testis—ovarian cancer	0.0021	0.00438	CbGeAlD
Halothane—KCNMA1—lymph node—ovarian cancer	0.00208	0.00434	CbGeAlD
Halothane—ATP5D—lymph node—ovarian cancer	0.00206	0.0043	CbGeAlD
Halothane—ATP2C1—lymph node—ovarian cancer	0.00203	0.00424	CbGeAlD
Halothane—ALB—testis—ovarian cancer	0.00191	0.00399	CbGeAlD
Halothane—GABRB3—testis—ovarian cancer	0.00178	0.00371	CbGeAlD
Halothane—CYP2B6—gonad—ovarian cancer	0.00167	0.00349	CbGeAlD
Halothane—GABRA2—lymph node—ovarian cancer	0.00153	0.0032	CbGeAlD
Halothane—GABRE—lymph node—ovarian cancer	0.00152	0.00318	CbGeAlD
Halothane—CYP2B6—female reproductive system—ovarian cancer	0.00149	0.00312	CbGeAlD
Halothane—CYP2C9—female reproductive system—ovarian cancer	0.00148	0.00309	CbGeAlD
Halothane—CYP2E1—female reproductive system—ovarian cancer	0.0014	0.00293	CbGeAlD
Halothane—ALB—lymph node—ovarian cancer	0.00139	0.00289	CbGeAlD
Halothane—CYP2B6—vagina—ovarian cancer	0.00135	0.00282	CbGeAlD
Halothane—CYP2B6—testis—ovarian cancer	0.00121	0.00252	CbGeAlD
Halothane—CYP2E1—testis—ovarian cancer	0.00113	0.00236	CbGeAlD
Halothane—CYP3A4—female reproductive system—ovarian cancer	0.00113	0.00236	CbGeAlD
Halothane—CYP2D6—female reproductive system—ovarian cancer	0.00111	0.00232	CbGeAlD
Halothane—CYP2D6—female gonad—ovarian cancer	0.00101	0.00211	CbGeAlD
Halothane—CYP2D6—testis—ovarian cancer	0.000896	0.00187	CbGeAlD
Halothane—RHO—Signaling Pathways—PTEN—ovarian cancer	7.94e-05	0.000152	CbGpPWpGaD
Halothane—GABRA4—Neuronal System—HRAS—ovarian cancer	7.94e-05	0.000152	CbGpPWpGaD
Halothane—GNG2—Hemostasis—AKT1—ovarian cancer	7.89e-05	0.000151	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—KRAS—ovarian cancer	7.86e-05	0.000151	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—PPP1CC—ovarian cancer	7.78e-05	0.000149	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—BRIP1—ovarian cancer	7.78e-05	0.000149	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—AKT1—ovarian cancer	7.75e-05	0.000149	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CAV1—ovarian cancer	7.7e-05	0.000148	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—PPP1CC—ovarian cancer	7.62e-05	0.000146	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—BRIP1—ovarian cancer	7.62e-05	0.000146	CbGpPWpGaD
Halothane—GABRA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.57e-05	0.000145	CbGpPWpGaD
Halothane—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	7.52e-05	0.000144	CbGpPWpGaD
Halothane—ALB—Metabolism—CYTB—ovarian cancer	7.49e-05	0.000144	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—ESR1—ovarian cancer	7.42e-05	0.000142	CbGpPWpGaD
Halothane—RHO—Disease—HRAS—ovarian cancer	7.4e-05	0.000142	CbGpPWpGaD
Halothane—GNG2—Metabolism—PIK3CD—ovarian cancer	7.37e-05	0.000141	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	7.32e-05	0.00014	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—IL6ST—ovarian cancer	7.3e-05	0.00014	CbGpPWpGaD
Halothane—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	7.26e-05	0.000139	CbGpPWpGaD
Halothane—GABRB2—Neuronal System—HRAS—ovarian cancer	7.26e-05	0.000139	CbGpPWpGaD
Halothane—GABRA1—Neuronal System—MAPK1—ovarian cancer	7.23e-05	0.000139	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—PIK3CA—ovarian cancer	7.22e-05	0.000139	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—VEGFA—ovarian cancer	7.17e-05	0.000138	CbGpPWpGaD
Halothane—ALB—Hemostasis—SOD1—ovarian cancer	7.17e-05	0.000138	CbGpPWpGaD
Halothane—ALB—Hemostasis—PPP2R1A—ovarian cancer	7.13e-05	0.000137	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—STAT3—ovarian cancer	7.1e-05	0.000136	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	7.1e-05	0.000136	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—NRAS—ovarian cancer	7.08e-05	0.000136	CbGpPWpGaD
Halothane—RHO—Disease—IL6—ovarian cancer	7.08e-05	0.000136	CbGpPWpGaD
Halothane—GABRA5—Neuronal System—HRAS—ovarian cancer	7.05e-05	0.000135	CbGpPWpGaD
Halothane—ND1—Metabolism—PTEN—ovarian cancer	7.03e-05	0.000135	CbGpPWpGaD
Halothane—ATP5D—Metabolism—PTEN—ovarian cancer	7.03e-05	0.000135	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—APC—ovarian cancer	7.01e-05	0.000135	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—PIK3CG—ovarian cancer	7.01e-05	0.000135	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—NRAS—ovarian cancer	7.01e-05	0.000135	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—TP53—ovarian cancer	6.99e-05	0.000134	CbGpPWpGaD
Halothane—GABRA3—Neuronal System—HRAS—ovarian cancer	6.92e-05	0.000133	CbGpPWpGaD
Halothane—GABRA2—Neuronal System—HRAS—ovarian cancer	6.8e-05	0.000131	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—MAPK3—ovarian cancer	6.78e-05	0.00013	CbGpPWpGaD
Halothane—GABRB3—Neuronal System—HRAS—ovarian cancer	6.76e-05	0.00013	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—MAPK3—ovarian cancer	6.72e-05	0.000129	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—HRAS—ovarian cancer	6.68e-05	0.000128	CbGpPWpGaD
Halothane—GABRG2—Neuronal System—HRAS—ovarian cancer	6.64e-05	0.000127	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—MYC—ovarian cancer	6.6e-05	0.000127	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	6.58e-05	0.000126	CbGpPWpGaD
Halothane—ALB—Metabolism—BRIP1—ovarian cancer	6.55e-05	0.000126	CbGpPWpGaD
Halothane—ALB—Metabolism—PPP1CC—ovarian cancer	6.55e-05	0.000126	CbGpPWpGaD
Halothane—RHO—Disease—AKT1—ovarian cancer	6.53e-05	0.000125	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	6.52e-05	0.000125	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—YAP1—ovarian cancer	6.47e-05	0.000124	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—MAPK1—ovarian cancer	6.46e-05	0.000124	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—EGFR—ovarian cancer	6.45e-05	0.000124	CbGpPWpGaD
Halothane—GNG2—Metabolism—PIK3CB—ovarian cancer	6.43e-05	0.000123	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—IL6—ovarian cancer	6.4e-05	0.000123	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—MAPK1—ovarian cancer	6.39e-05	0.000123	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—EGFR—ovarian cancer	6.39e-05	0.000123	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—NME2—ovarian cancer	6.27e-05	0.00012	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—CYTB—ovarian cancer	6.18e-05	0.000119	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—PIK3CD—ovarian cancer	6.17e-05	0.000118	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—CYTB—ovarian cancer	6.13e-05	0.000118	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—PIK3CA—ovarian cancer	6.11e-05	0.000117	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—KRAS—ovarian cancer	6.1e-05	0.000117	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—KRAS—ovarian cancer	6.04e-05	0.000116	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.99e-05	0.000115	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—AKT1—ovarian cancer	5.9e-05	0.000113	CbGpPWpGaD
Halothane—GABRA1—Neuronal System—HRAS—ovarian cancer	5.8e-05	0.000111	CbGpPWpGaD
Halothane—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	5.73e-05	0.00011	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—PIK3CA—ovarian cancer	5.6e-05	0.000107	CbGpPWpGaD
Halothane—GNG2—Metabolism—PTEN—ovarian cancer	5.55e-05	0.000107	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—PIK3CA—ovarian cancer	5.55e-05	0.000106	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	5.54e-05	0.000106	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—ERBB2—ovarian cancer	5.45e-05	0.000104	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—TP53—ovarian cancer	5.42e-05	0.000104	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—PPP1CC—ovarian cancer	5.41e-05	0.000104	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—BRIP1—ovarian cancer	5.41e-05	0.000104	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—PIK3CB—ovarian cancer	5.37e-05	0.000103	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—MTOR—ovarian cancer	5.37e-05	0.000103	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—BRIP1—ovarian cancer	5.36e-05	0.000103	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—PPP1CC—ovarian cancer	5.36e-05	0.000103	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—FASN—ovarian cancer	5.27e-05	0.000101	CbGpPWpGaD
Halothane—ALB—Hemostasis—CAV1—ovarian cancer	5.24e-05	0.000101	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	5.24e-05	0.000101	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—YAP1—ovarian cancer	5.22e-05	0.0001	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—SLC5A5—ovarian cancer	5.18e-05	9.95e-05	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—HRAS—ovarian cancer	5.18e-05	9.94e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CXCL8—ovarian cancer	5.16e-05	9.91e-05	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—HRAS—ovarian cancer	5.13e-05	9.84e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—YAP1—ovarian cancer	5.11e-05	9.8e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CDKN1B—ovarian cancer	5.04e-05	9.68e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—SLC2A1—ovarian cancer	5.01e-05	9.61e-05	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—AKT1—ovarian cancer	4.99e-05	9.57e-05	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	4.99e-05	9.56e-05	CbGpPWpGaD
Halothane—ATP5D—Metabolism—PIK3CA—ovarian cancer	4.96e-05	9.52e-05	CbGpPWpGaD
Halothane—ND1—Metabolism—PIK3CA—ovarian cancer	4.96e-05	9.52e-05	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—IL6—ovarian cancer	4.96e-05	9.52e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CASP3—ovarian cancer	4.94e-05	9.48e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—IL2—ovarian cancer	4.94e-05	9.47e-05	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—IL6—ovarian cancer	4.91e-05	9.42e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CCND1—ovarian cancer	4.81e-05	9.23e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—CYP1B1—ovarian cancer	4.8e-05	9.21e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—PIK3CG—ovarian cancer	4.77e-05	9.16e-05	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.77e-05	9.15e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CTNNB1—ovarian cancer	4.76e-05	9.14e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—MMP9—ovarian cancer	4.67e-05	8.96e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—PTEN—ovarian cancer	4.64e-05	8.91e-05	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—AKT1—ovarian cancer	4.58e-05	8.78e-05	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—AKT1—ovarian cancer	4.53e-05	8.69e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—YAP1—ovarian cancer	4.39e-05	8.43e-05	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.35e-05	8.34e-05	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	4.33e-05	8.3e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	4.26e-05	8.17e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—FASN—ovarian cancer	4.25e-05	8.16e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—PIK3CD—ovarian cancer	4.2e-05	8.05e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—VEGFA—ovarian cancer	4.19e-05	8.05e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—SLC5A5—ovarian cancer	4.18e-05	8.03e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—FASN—ovarian cancer	4.17e-05	7.99e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—STAT3—ovarian cancer	4.15e-05	7.97e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—NRAS—ovarian cancer	4.14e-05	7.95e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—SLC5A5—ovarian cancer	4.1e-05	7.86e-05	CbGpPWpGaD
Halothane—ND1—Metabolism—AKT1—ovarian cancer	4.05e-05	7.78e-05	CbGpPWpGaD
Halothane—ATP5D—Metabolism—AKT1—ovarian cancer	4.05e-05	7.78e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—CYTB—ovarian cancer	4.04e-05	7.76e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—SLC2A1—ovarian cancer	4.04e-05	7.75e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—MAPK3—ovarian cancer	3.97e-05	7.61e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—SLC2A1—ovarian cancer	3.96e-05	7.59e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—ABCB1—ovarian cancer	3.95e-05	7.58e-05	CbGpPWpGaD
Halothane—GNG2—Metabolism—PIK3CA—ovarian cancer	3.92e-05	7.52e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.91e-05	7.49e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—TYMS—ovarian cancer	3.88e-05	7.45e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—CYP1B1—ovarian cancer	3.87e-05	7.43e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—MYC—ovarian cancer	3.86e-05	7.4e-05	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.82e-05	7.33e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—CYP1B1—ovarian cancer	3.79e-05	7.28e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—MAPK1—ovarian cancer	3.78e-05	7.24e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—EGFR—ovarian cancer	3.77e-05	7.24e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—PIK3CB—ovarian cancer	3.66e-05	7.02e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—YAP1—ovarian cancer	3.63e-05	6.96e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—YAP1—ovarian cancer	3.59e-05	6.9e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—FASN—ovarian cancer	3.58e-05	6.87e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—KRAS—ovarian cancer	3.57e-05	6.84e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.56e-05	6.82e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—BRIP1—ovarian cancer	3.53e-05	6.78e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—PPP1CC—ovarian cancer	3.53e-05	6.78e-05	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	3.53e-05	6.78e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—SLC5A5—ovarian cancer	3.52e-05	6.76e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	3.44e-05	6.59e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—SLC2A1—ovarian cancer	3.4e-05	6.52e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	3.36e-05	6.46e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—IL2—ovarian cancer	3.36e-05	6.44e-05	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.33e-05	6.39e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—PIK3CA—ovarian cancer	3.28e-05	6.29e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—CYP1B1—ovarian cancer	3.26e-05	6.26e-05	CbGpPWpGaD
Halothane—GNG2—Metabolism—AKT1—ovarian cancer	3.2e-05	6.14e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—ABCB1—ovarian cancer	3.19e-05	6.12e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—TP53—ovarian cancer	3.17e-05	6.08e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—TYMS—ovarian cancer	3.13e-05	6.01e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—CAV1—ovarian cancer	3.13e-05	6e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.13e-05	6e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—ABCB1—ovarian cancer	3.12e-05	5.99e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—TYMS—ovarian cancer	3.07e-05	5.89e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—HRAS—ovarian cancer	3.03e-05	5.81e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—FASN—ovarian cancer	2.96e-05	5.67e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—FASN—ovarian cancer	2.93e-05	5.62e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—SLC5A5—ovarian cancer	2.91e-05	5.58e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—IL6—ovarian cancer	2.9e-05	5.57e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—PPP2R1A—ovarian cancer	2.89e-05	5.55e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—SLC5A5—ovarian cancer	2.88e-05	5.53e-05	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.88e-05	5.52e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—VEGFA—ovarian cancer	2.85e-05	5.48e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—PIK3CG—ovarian cancer	2.85e-05	5.47e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—NRAS—ovarian cancer	2.82e-05	5.41e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—SLC2A1—ovarian cancer	2.81e-05	5.39e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—SLC2A1—ovarian cancer	2.78e-05	5.34e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.73e-05	5.23e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—MAPK3—ovarian cancer	2.7e-05	5.18e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—CYP1B1—ovarian cancer	2.69e-05	5.16e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—ABCB1—ovarian cancer	2.68e-05	5.15e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—AKT1—ovarian cancer	2.68e-05	5.13e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—CYP1B1—ovarian cancer	2.67e-05	5.12e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—TYMS—ovarian cancer	2.64e-05	5.06e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—MAPK1—ovarian cancer	2.57e-05	4.93e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—CAV1—ovarian cancer	2.52e-05	4.84e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—PIK3CD—ovarian cancer	2.51e-05	4.81e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—CAV1—ovarian cancer	2.47e-05	4.74e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—KRAS—ovarian cancer	2.43e-05	4.66e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	2.39e-05	4.58e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—YAP1—ovarian cancer	2.37e-05	4.55e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	2.37e-05	4.54e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.36e-05	4.52e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—PIK3CG—ovarian cancer	2.3e-05	4.41e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—PIK3CG—ovarian cancer	2.25e-05	4.32e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—PIK3CA—ovarian cancer	2.23e-05	4.28e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—ABCB1—ovarian cancer	2.22e-05	4.25e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—ABCB1—ovarian cancer	2.2e-05	4.22e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—PIK3CB—ovarian cancer	2.18e-05	4.19e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—TYMS—ovarian cancer	2.18e-05	4.18e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—TYMS—ovarian cancer	2.16e-05	4.14e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—TP53—ovarian cancer	2.16e-05	4.14e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—CAV1—ovarian cancer	2.12e-05	4.08e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—HRAS—ovarian cancer	2.06e-05	3.96e-05	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.03e-05	3.89e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—PIK3CD—ovarian cancer	2.02e-05	3.88e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—PIK3CD—ovarian cancer	1.98e-05	3.8e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—PIK3CG—ovarian cancer	1.94e-05	3.71e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—FASN—ovarian cancer	1.93e-05	3.71e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.9e-05	3.65e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—PTEN—ovarian cancer	1.89e-05	3.62e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.84e-05	3.52e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—AKT1—ovarian cancer	1.82e-05	3.49e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—PIK3CB—ovarian cancer	1.76e-05	3.38e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.76e-05	3.38e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—CAV1—ovarian cancer	1.75e-05	3.37e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—CAV1—ovarian cancer	1.74e-05	3.34e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—PIK3CB—ovarian cancer	1.73e-05	3.31e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—PIK3CD—ovarian cancer	1.7e-05	3.26e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.66e-05	3.19e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—PIK3CG—ovarian cancer	1.6e-05	3.07e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—PIK3CG—ovarian cancer	1.58e-05	3.04e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.56e-05	2.99e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—PTEN—ovarian cancer	1.52e-05	2.92e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—PTEN—ovarian cancer	1.49e-05	2.86e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—PIK3CB—ovarian cancer	1.48e-05	2.85e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.45e-05	2.78e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—TYMS—ovarian cancer	1.42e-05	2.73e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—PIK3CD—ovarian cancer	1.4e-05	2.7e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—PIK3CD—ovarian cancer	1.39e-05	2.67e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—PIK3CA—ovarian cancer	1.33e-05	2.55e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—PTEN—ovarian cancer	1.28e-05	2.46e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—PIK3CB—ovarian cancer	1.22e-05	2.35e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—PIK3CB—ovarian cancer	1.21e-05	2.33e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—CAV1—ovarian cancer	1.15e-05	2.2e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—AKT1—ovarian cancer	1.09e-05	2.09e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—PIK3CA—ovarian cancer	1.07e-05	2.06e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—PTEN—ovarian cancer	1.06e-05	2.03e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—PIK3CA—ovarian cancer	1.05e-05	2.02e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—PTEN—ovarian cancer	1.05e-05	2.01e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.04e-05	2e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—PIK3CD—ovarian cancer	9.18e-06	1.76e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—PIK3CA—ovarian cancer	9.04e-06	1.73e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—AKT1—ovarian cancer	8.77e-06	1.68e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—AKT1—ovarian cancer	8.59e-06	1.65e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—PIK3CB—ovarian cancer	8.01e-06	1.54e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—PIK3CA—ovarian cancer	7.46e-06	1.43e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—PIK3CA—ovarian cancer	7.4e-06	1.42e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—AKT1—ovarian cancer	7.39e-06	1.42e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—PTEN—ovarian cancer	6.92e-06	1.33e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—AKT1—ovarian cancer	6.1e-06	1.17e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—AKT1—ovarian cancer	6.05e-06	1.16e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—PIK3CA—ovarian cancer	4.88e-06	9.36e-06	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—AKT1—ovarian cancer	3.99e-06	7.65e-06	CbGpPWpGaD
